Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $28,218 | 16 | 79.9% |
| Food and Beverage | $6,960 | 503 | 19.7% |
| Education | $143.35 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $28,218 | 16 | $0 (2018) |
| Novo Nordisk Inc | $1,272 | 91 | $0 (2024) |
| ABBVIE INC. | $1,139 | 120 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $658.64 | 40 | $0 (2024) |
| PFIZER INC. | $566.32 | 39 | $0 (2024) |
| Lilly USA, LLC | $467.87 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $457.85 | 22 | $0 (2024) |
| Exact Sciences Corporation | $306.20 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $268.53 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $239.45 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,958 | 123 | ABBVIE INC. ($382.19) |
| 2023 | $1,559 | 102 | AbbVie Inc. ($332.06) |
| 2022 | $958.67 | 74 | Novo Nordisk Inc ($220.09) |
| 2021 | $864.12 | 70 | AbbVie Inc. ($203.98) |
| 2020 | $874.66 | 64 | Allergan, Inc. ($224.65) |
| 2019 | $293.13 | 19 | Novo Nordisk Inc ($69.78) |
| 2018 | $7,104 | 18 | Shire North American Group Inc ($6,922) |
| 2017 | $21,710 | 53 | Shire North American Group Inc ($21,296) |
All Payment Transactions
523 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Obesity | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Biological | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Obesity | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: PAIN | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Biological | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 697 | 1,024 | $172,509 | $64,323 |
| 2022 | 19 | 828 | 1,272 | $198,276 | $76,043 |
| 2021 | 19 | 818 | 1,296 | $198,299 | $77,950 |
| 2020 | 12 | 543 | 870 | $146,735 | $50,425 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 423 | $83,331 | $32,012 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 127 | 127 | $39,624 | $15,465 | 39.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $11,219 | $3,673 | 32.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 41 | 41 | $7,503 | $3,108 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 39 | $5,187 | $2,235 | 43.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $5,564 | $2,030 | 36.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 109 | 109 | $5,232 | $1,874 | 35.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $3,149 | $1,337 | 42.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,561 | $776.61 | 30.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 89 | $5,963 | $744.66 | 12.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $1,206 | $511.92 | 42.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 23 | 30 | $1,350 | $370.50 | 27.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 20 | 21 | $210.00 | $96.02 | 45.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 41 | $410.00 | $90.20 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 512 | $100,864 | $38,714 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 142 | 142 | $44,304 | $17,547 | 39.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 50 | 50 | $9,150 | $3,471 | 37.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 11 | 11 | $4,268 | $2,781 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 46 | $6,118 | $2,376 | 38.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $2,924 | $2,248 | 76.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $5,564 | $2,013 | 36.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 90 | 90 | $4,320 | $1,557 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 54 | 54 | $3,618 | $1,466 | 40.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 38 | 38 | $2,546 | $1,038 | 40.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 41 | 109 | $7,303 | $1,036 | 14.2% |
About Dr. Megan Settle, MD
Dr. Megan Settle, MD is a Family Medicine healthcare provider based in Goodlettsville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1578829594.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Megan Settle, MD has received a total of $35,322 in payments from pharmaceutical and medical device companies, with $1,958 received in 2024. These payments were reported across 523 transactions from 42 companies. The most common payment nature is "Consulting Fee" ($28,218).
As a Medicare-enrolled provider, Settle has provided services to 2,886 Medicare beneficiaries, totaling 4,462 services with total Medicare billing of $268,741. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Goodlettsville, TN
- Active Since 04/03/2012
- Last Updated 02/10/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578829594
Products in Payments
- JARDIANCE (Drug) $576.22
- VRAYLAR (Drug) $495.99
- UBRELVY (Drug) $484.81
- Ozempic (Drug) $390.02
- QULIPTA (Drug) $350.89
- Cologuard Collection Kit (Device) $306.20
- Wegovy (Drug) $221.54
- NURTEC ODT (Drug) $220.61
- XARELTO (Drug) $191.76
- Rybelsus (Drug) $188.26
- Saxenda (Drug) $173.76
- Veozah (Drug) $167.55
- MOUNJARO (Drug) $152.65
- REXULTI (Drug) $144.73
- FARXIGA (Drug) $130.21
- FREESTYLE LIBRE 2 (Device) $124.17
- TRELEGY ELLIPTA (Drug) $119.83
- VIVITROL (Drug) $119.47
- Victoza (Drug) $118.26
- TRULICITY (Drug) $116.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goodlettsville
Dr. Ted Miller, M.d, M.D
Family Medicine — Payments: $7,885
Dr. Robert Ferland, M.d, M.D
Family Medicine — Payments: $7,568
Dr. Donald Spisak, Do, DO
Family Medicine — Payments: $6,212
Dr. James Botsko, M.d, M.D
Family Medicine — Payments: $2,677
Robert Pilkinton, Md, MD
Family Medicine — Payments: $1,243
Dr. John Baites,, M.d, M.D
Family Medicine — Payments: $776.02